€86.38
0.64% yesterday
Borsa Italiana, Aug 25, 05:35 pm CET
ISIN
IT0003492391
Symbol
DIA

DiaSorin S.p.A. Stock price

€86.38
-4.12 4.55% 1M
-13.92 13.88% 6M
-13.18 13.24% YTD
-15.82 15.48% 1Y
-50.62 36.95% 3Y
-77.52 47.30% 5Y
+46.49 116.53% 10Y
+74.31 615.52% 20Y
Borsa Italiana, Closing price Mon, Aug 25 2025
-0.56 0.64%
ISIN
IT0003492391
Symbol
DIA

Key metrics

Basic
Market capitalization
€4.7b
Enterprise Value
€5.4b
Net debt
€691.9m
Cash
€174.4m
Shares outstanding
53.9m
Valuation (TTM | estimate)
P/E
20.5 | 22.0
P/S
3.1 | 3.8
EV/Sales
3.6 | 4.3
EV/FCF
32.6
P/B
3.1
Dividends
DPS
€1.20
Yield 1Y | 5Y
1.4% | 0.9%
Growth 1Y | 5Y
4.3% | 4.8%
Payout 1Y | 3Y
35.6% | 32.7%
Increased
18 Years
Financials (TTM | estimate)
Revenue
€1.5b | €1.3b
EBITDA
€363.1m | €429.8m
EBIT
€342.5m | €315.6m
Net Income
€237.5m | €212.8m
Free Cash Flow
€166.0m
Growth (TTM | estimate)
Revenue
29.4% | 5.7%
EBITDA
36.4% | 51.2%
EBIT
39.2% | 19.1%
Net Income
41.6% | 13.1%
Free Cash Flow
-12.5%
Margin (TTM | estimate)
Gross
65.6%
EBITDA
24.2% | 34.3%
EBIT
22.8%
Net
15.8% | 17.0%
Free Cash Flow
11.1%
Financial Health
Equity Ratio
54.5%
Return on Equity
10.4%
ROCE
14.8%
ROIC
10.4%
Debt/Equity
0.6
More
EPS
€4.2
FCF per Share
€3.1
Short interest
-
Employees
3k
Rev per Employee
€360.0k
Show more

Is DiaSorin S.p.A. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

DiaSorin S.p.A. Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a DiaSorin S.p.A. forecast:

8x Buy
44%
9x Hold
50%
1x Sell
6%

Analyst Opinions

18 Analysts have issued a DiaSorin S.p.A. forecast:

Buy
44%
Hold
50%
Sell
6%

Financial data from DiaSorin S.p.A.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
1,502 1,502
29% 29%
100%
- Direct Costs 517 517
26% 26%
34%
986 986
31% 31%
66%
- Selling and Administrative Expenses 519 519
24% 24%
35%
- Research and Development Expense 97 97
43% 43%
6%
363 363
36% 36%
24%
- Depreciation and Amortization 21 21
2% 2%
1%
EBIT (Operating Income) EBIT 342 342
39% 39%
23%
Net Profit 238 238
42% 42%
16%

In millions EUR.

Don't miss a Thing! We will send you all news about DiaSorin S.p.A. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

DiaSorin SpA engages in the development, production, and marketing of reagent kits for in vitro diagnostics. It specializes in the provision of immunodiagnostics and molecular diagnostics solutions which meet the needs of the following clinical areas: infectious diseases, cardiac markers, bone metabolism, hepatitis & retrovirus, oncology and endocrinology. The company was founded in 1968 and is headquartered in Vercelli, Italy.

Head office Italy
CEO Carlo Rosa
Employees 3,279
Founded 1968
Website int.diasorin.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today